Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A de Boer

Showing results (181-190 of 1,446) with videos related to

Pageof 145
Sort By:
British Journal of Clinical Pharmacology|June 10, 2000
The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wardsH S Lau, C Florax, A J Porsius, et al.
Veterinary Microbiology|July 1, 1995
Pathogenesis of swine vesicular disease after exposure of pigs to an infected environmentA Dekker, P Moonen, E A de Boer-Luijtze, et al.
Musculoskeletal Surgery|December 5, 2016
Is there any influence of humeral component retroversion on range of motion and clinical outcome in reverse shoulder arthroplasty? A clinical studyF A de Boer, P M van Kampen, P E Huijsmans
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 7, 2017
Re: Consensus definition for placental fetal growth restriction: a Delphi procedureC A Schreurs, B W J Mol, M A de Boer
Maternal and Child Health Journal|August 4, 2019
Analysis of Publication Interest on Preterm Birth Over Two DecadesLaura Visser, Marjon A de Boer, Christianne J M de Groot
Cardiovascular Drugs and Therapy|January 26, 2008
Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al."A M S Belonje, R A de Boer, A A Voors
British Journal of Clinical Pharmacology|July 1, 1991
The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172A De Boer, J C Stiekema, M Danhof, et al.
Expert Opinion on Pharmacotherapy|July 31, 2007
Nebivolol: third-generation beta-blockadeRudolf A de Boer, Adriaan A Voors, Dirk J van Veldhuisen
The Journal of Cell Biology|October 30, 2009
HORMONAL CONTROL OF REVERSIBLE DEGENERATION OF FLIGHT MUSCLE IN THE COLORADO POTATO BEETLE, LEPTINOTARSA DECEMLINEATA SAY (COLEOPTERA)D Stegwee, E C Kimmel, J A de Boer, et al.
The Netherlands Journal of Medicine|May 9, 1998
Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infectionW A de Boer, R J van Etten, P M Schneeberger
Pageof 145

Showing results (181-190 of 1,446) with videos related to

Sort By:
Pageof 145
British Journal of Clinical Pharmacology|June 10, 2000
The completeness of medication histories in hospital medical records of patients admitted to general internal medicine wardsH S Lau, C Florax, A J Porsius, et al.
Veterinary Microbiology|July 1, 1995
Pathogenesis of swine vesicular disease after exposure of pigs to an infected environmentA Dekker, P Moonen, E A de Boer-Luijtze, et al.
Musculoskeletal Surgery|December 5, 2016
Is there any influence of humeral component retroversion on range of motion and clinical outcome in reverse shoulder arthroplasty? A clinical studyF A de Boer, P M van Kampen, P E Huijsmans
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|January 7, 2017
Re: Consensus definition for placental fetal growth restriction: a Delphi procedureC A Schreurs, B W J Mol, M A de Boer
Maternal and Child Health Journal|August 4, 2019
Analysis of Publication Interest on Preterm Birth Over Two DecadesLaura Visser, Marjon A de Boer, Christianne J M de Groot
Cardiovascular Drugs and Therapy|January 26, 2008
Recombinant human Epo treatment: beneficial in chronic kidney disease, chronic heart failure, or both? Editorial to: "Correction of anemia with erythropoietin in chronic kidney disease (stage 3 or 4): effects on cardiac performance by Pappas et al."A M S Belonje, R A de Boer, A A Voors
British Journal of Clinical Pharmacology|July 1, 1991
The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172A De Boer, J C Stiekema, M Danhof, et al.
Expert Opinion on Pharmacotherapy|July 31, 2007
Nebivolol: third-generation beta-blockadeRudolf A de Boer, Adriaan A Voors, Dirk J van Veldhuisen
The Journal of Cell Biology|October 30, 2009
HORMONAL CONTROL OF REVERSIBLE DEGENERATION OF FLIGHT MUSCLE IN THE COLORADO POTATO BEETLE, LEPTINOTARSA DECEMLINEATA SAY (COLEOPTERA)D Stegwee, E C Kimmel, J A de Boer, et al.
The Netherlands Journal of Medicine|May 9, 1998
Four-day lansoprazole-quadruple therapy in the routine treatment of Helicobacter pylori infectionW A de Boer, R J van Etten, P M Schneeberger
Pageof 145